Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 12, 2013 08:30 ET | Source: BG Medicine, Inc.

BG Medicine Welcomes Inclusion of Galectin-3 as Biomarker of Myocardial Fibrosis in 2013 ACCF/AHA Guideline for Management of Heart Failure

WALTHAM, Mass., June 12, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) announced today that galectin-3 testing has been recognized for the first time in the newly issued 2013 American...
May 28, 2013 08:30 ET | Source: BG Medicine, Inc.

BG Medicine Announces Late-Breaker Oral Presentation of New Data on the BGM Galectin-3(R) Test in Heart Failure

WALTHAM, Mass., May 28, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced the presentation of new clinical research data on the BGM Galectin-3® test in heart disease at the...
May 10, 2013 17:04 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

WALTHAM, Mass., May 10, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a diagnostics company focused on the development and commercialization of novel cardiovascular tests, announced today...
May 09, 2013 07:46 ET | Source: BG Medicine, Inc.

BG Medicine Appoints Dr. Paul Sohmer as Chief Executive Officer

WALTHAM, Mass., May 9, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a diagnostics company focused on the development and commercialization of novel cardiovascular tests, today announced...
May 09, 2013 07:45 ET | Source: BG Medicine, Inc.

BG Medicine Reports 2013 First Quarter Financial Results

Abbott and bioMérieux Obtain CE Mark and Launch Galectin-3 Tests in EU BGM Galectin-3 Revenues Coupled With Operational Discipline Drive Improved Financial Results Q1 BGM Galectin-3 test...
May 08, 2013 07:00 ET | Source: BG Medicine, Inc.

Trenton Health Team Adopts Novel Diagnostic Tool, BGM Galectin-3(R) Test, to Reduce Hospital Readmissions

TRENTON, N.J. and WALTHAM, Mass., May 8, 2013 (GLOBE NEWSWIRE) -- The Trenton Health Team (THT) and BG Medicine (Nasdaq:BGMD) today announced that THT has adopted the BGM Galectin-3® test...
May 02, 2013 08:30 ET | Source: BG Medicine, Inc.

BG Medicine to Announce First Quarter 2013 Financial Results and Host Conference Call on Thursday, May 9, 2013

WALTHAM, Mass., May 2, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that the company will host a conference call and webcast on Thursday, May 9 at 8:30 a.m. Eastern...
April 10, 2013 08:18 ET | Source: BG Medicine, Inc.

BG Medicine Welcomes CE Mark for Galectin-3 Test

WALTHAM, Mass., April 10, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, welcomed the...
March 13, 2013 07:45 ET | Source: BG Medicine, Inc.

BG Medicine Reports Fourth Quarter and Full Year 2012 Financial Results and Provides 2013 Outlook

Q4 Revenues nearly triple from Q4 2011 Product margins increase 10% from Q4 2011 January 2013 $12.8 million public offering supplements Q4 2012 cash of $13.2 million bioMérieux...
March 06, 2013 08:30 ET | Source: BG Medicine, Inc.

BG Medicine to Announce Fourth Quarter and Year-End 2012 Financial Results and Host Conference Call on Wednesday, March 13, 2013

WALTHAM, Mass., March 6, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that the company will host a conference call and webcast on Wednesday, March 13 at 8:30 a.m. Eastern...